Tradestie Institutional Equity Comparison Engine

EVGN vs SRZN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRZN Overall Edge

SRZN Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EVGN trades at N/M Forward P/E with -858.2% operating margin (-60.7% YoY revenue) versus SRZN at N/M Forward P/E and -485.4% operating margin (+408.6% YoY). In options structure, EVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EVGN N/M vs SRZN N/M Fwd P/E
Growth & Margin Winner SRZN
Op Margin -858.2% vs -485.4% ยท YoY -60.7% vs +408.6%
Momentum & Technical Winner SRZN
1Y -71.9% vs +131.0% ยท 52W Pos 9% vs 69%
Options & Structure Winner SRZN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (5th %ile IV)
EVGN NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap $6.0M
1M Return -7.58%
1Y Return -71.89%
Forward P/E N/M
Unified AI Score
44.1 / 100 HOLD
Tech 42.0 Fund 44.0 Flow 50.0 Mom 60.0
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$29.98
-7.24% 1D
Market Cap $616.1M
1M Return +25.76%
1Y Return +130.97%
Forward P/E N/M
Unified AI Score
46.6 / 100 HOLD
Tech 40.0 Fund 33.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVGN -71.89% SRZN +130.97% Spread: +202.86 pp (SRZN Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EVGN Revenue SRZN Revenue EVGN Op. Margin SRZN Op. Margin Margin Edge
Q3 '25 $0M $0M -873.1% -1107.3% EVGN
Q4 '25 $0M $0M -1659.9% -2393.8% EVGN
Q1 '26 $0M $20M -943.1% -209.1% SRZN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVGN (0) vs SRZN (7)
Institutional Metric EVGN SRZN Criterion Row Winner
Market Capitalization Scale $6.0M $616.1M Larger Scale SRZN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -60.7% +408.6% Higher Growth SRZN
Operating Margin (TTM) Profitability -858.2% -485.4% Higher Margin SRZN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -182.8% -62.8% Higher ROE SRZN
52-Week Range Position Momentum 9% ($0โ€“$1) 69% ($12โ€“$38) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime 1.37ฮฒ ยท 138% Vol 1.29ฮฒ ยท 67% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 44.1 / 100 (HOLD) 46.6 / 100 (HOLD) Higher Composite SRZN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVGN vs SRZN Buy Guide
EVGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EVGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRZN CONSOLIDATION
38d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVGN nor SRZN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.